Cardiovascular and non-cardiovascular comorbidities are frequently observed in heart
failure patients, complicating the therapeutic management and leading to poor prognosis …

With the aging of the population and improvement of life expectancy of patients with heart
disease, there is an increase in non-cardiovascular (CV) comorbidities affecting chronic …

Aims Improvement of left ventricular ejection fraction is a major goal of heart failure (HF)
treatment. However, data on clinical characteristics, exercise performance and prognosis in …

Objective: To compare clinical outcomes in diabetic patients with heart failure managed by
insulin with those managed by non-insulin (oral hypoglycemic agents and/or lifestyle …

Background Due to advances in medical treatments, a substantial proportion of heart failure
(HF) patients with reduced left ventricular ejection fraction (EF, HFrEF) have experienced …

The coexistence of diabetes mellitus (DM) and heart failure (HF) is frequent and is
associated with a higher risk of hospitalization for HF and all-cause and cardiovascular …

Abstract β-blockers represent a mainstay in the pharmacological approach to patients
affected by heart failure with reduced ejection fraction (HFrEF). However, underuse of this …

Background: Diabetes mellitus worsens outcomes in patients suffering from heart disease
undergoing cardiac procedures. Objectives: To investigate the impact of diabetes in patients …

Cardiopulmonary exercise test (CPET) has become pivotal in the functional evaluation of
patients with chronic heart failure (HF), supplying a holistic evaluation both in terms of …

Abstract Background/Aim The study aims to describe the role of diabetes in patients with
heart failure. Methods In all, 1052 chronic heart failure patients were included in the …